Euro Coop Position on Antimicrobial Resistance
15.11.2016 17:50:43
In September 2016, the G20 recognised Antimicrobial Resistance as posing “a serious threat to public health, growth and global economic stability”. Antimicrobial Resistance or AMR occurs when microorganisms mutate and become resistant to antimicrobial drugs. As a consequence of these mutations, those medicines that are used currently become ineffective; the illness is prolonged and may even become life-threatening.
Current measures are not enough to counteract AMR. Euro Coop therefore calls on all stakeholders to play their part in order to tackle this important public health threat and to consider AMR as a priority globally.
Find out more about Euro Coop's position here.
Latest Consumer Policy news
EU Commission Unveils Retail Transition Pathway
The EU Commission unveiled the Transition Pathway for a More Resilient, Digital and...
Investing in Women: Accelerating Progress through Cooperation
Euro Coop celebrates International Women's Day 2024, emphasizing the co-operative...
EU Code of Conduct: Insights from the 2023 Mapping Report
In July 2021, the EU Commission launched the EU Code of Conduct on Responsible Food Business...
Latest Consumer Policy stories
Brussels - Board Meeting and Joint Seminar on Participative Democracy and Energy Communities.
On April 4, Euro Coop Board members convened in Brussels for their meeting on the present and...
Celebrating International Consumer Rights Day 2024: Promoting Fair and Responsible AI for Consumers
As we celebrate International Consumer Rights Day on March 15, 2024, under the theme...
Euro Coop and Coop Italia: Partners in Sustainable Energy Initiatives
Euro Coop takes pride in partnering with Coop Italia in its participation in the...